News

Nimble collaborates Genentech to discover, develop peptide-based therapeutics

The collaboration would leverage Nimble's proprietary peptide synthesis, screening and optimization platform

Feb 24, 2020

By : Team ABLE

FDA to ensure smooth regulatory transition of Insulin and other biological products

On March 23, 2020, an application for a biological product approved under the FD&C Act, including applications for insulins and other biological products, will be deemed to be a license for the product under the Public Health Service (PHS) Act.

Feb 24, 2020

By : Team ABLE

Queensland researchers achieve proof-of-concept milestonein COVID-19 vaccine quest

A University of Queensland team has met a key milestone in their fast-tracked research to develop a vaccine for the coronavirus, COVID-19.

Feb 24, 2020

By : Team ABLE

IIIM Jammu, Canadian firm IndusCannsign pact on cannabis medicinal project

This project will yield international standard, export quality medicinal drug for pain relief in cancer, diabetic and neuropathy.

Feb 24, 2020

By : Team ABLE

C-CAMP, University of Basel ink LoI to boost life sciences’innovations

The LoI is a formal initiation of the Indo Swiss Life Sciences Sister Innovation Hub that aims to promote deep science and deep tech innovations with societal impact in life sciences in both countries.

Feb 21, 2020

By : Team ABLE